Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride and finasteride affect different cell types differently.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

Men with early hair loss may have higher insulin resistance and should be checked for related health issues.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Testosterone may slow down wound healing and increase inflammation.

DHT, a testosterone byproduct, causes male pattern baldness.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Red deer only have androgen receptors in neck hair cells for mane growth during breeding season.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Si Jun Zi Tang may slow aging by affecting specific cell signaling pathways.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Early NAS level changes affect alcohol consumption vulnerability.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.